These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 16769443

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.
    Kuniholm MH, Aladashvili M, Del Rio C, Stvilia K, Gabelia N, Chitale RA, Tsertsvadze T, Nelson KE.
    Subst Use Misuse; 2008; 43(10):1424-37. PubMed ID: 18696377
    [Abstract] [Full Text] [Related]

  • 3. HIV sexual risk behaviors among injection drug users in Shanghai.
    Zhao M, Du J, Lu GH, Wang QY, Xu H, Zhu M, McCoy CB.
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S43-7. PubMed ID: 16769445
    [Abstract] [Full Text] [Related]

  • 4. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD, Hagan H, Garfein RS, Sabin K, Weinbaum C, Thiede H.
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N, Chkhartishvili N, Abutidze A, Gatserelia L, Sharvadze L.
    Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A, Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J.
    Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [Abstract] [Full Text] [Related]

  • 11. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W, Vu L, Adebajo SB, Abiodun L, Sheehy M, Karlyn A, Njab J, Ahonsi B, Issa BK, Idogho O.
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [Abstract] [Full Text] [Related]

  • 12. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012.
    Li L, Assanangkornchai S, Duo L, McNeil E, Li J.
    PLoS One; 2014 Aug; 9(9):e106899. PubMed ID: 25203256
    [Abstract] [Full Text] [Related]

  • 13. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
    Alipour A, Haghdoost AA, Sajadi L, Zolala F.
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
    [Abstract] [Full Text] [Related]

  • 14. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C, Horth R, Boothe M, Sathane I, Young P, Chitsondzo Langa D, Condula M, Ricardo H, Dengo Baloi L, Cummings B, Schaad N, Gouveia L, Teodoro E, Raymond HF.
    BMC Infect Dis; 2019 Dec 02; 19(1):1022. PubMed ID: 31791273
    [Abstract] [Full Text] [Related]

  • 15. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
    Quan VM, Go VF, Nam le V, Bergenstrom A, Thuoc NP, Zenilman J, Latkin C, Celentano DD.
    AIDS Care; 2009 Jan 02; 21(1):7-16. PubMed ID: 19085215
    [Abstract] [Full Text] [Related]

  • 16. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML.
    BMC Public Health; 2011 May 19; 11():351. PubMed ID: 21595969
    [Abstract] [Full Text] [Related]

  • 17. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP, Hagan H, Lyubenova A, Tomov N, Vasilev G, Krasteva D, Des Jarlais DC.
    Int J STD AIDS; 2006 Sep 19; 17(9):621-6. PubMed ID: 16942654
    [Abstract] [Full Text] [Related]

  • 18. [Risk behaviours and seroprevalence to HIV, HBV and HCV in patients of the AIDS information and prevention center in Valencia, Spain].
    Alfonso Gil R, Hurtado Navarro I, Espacio Casanovas A, Santos Rubio G, Tomás Dols S.
    Gac Sanit; 1999 Sep 19; 13(1):16-21. PubMed ID: 10217673
    [Abstract] [Full Text] [Related]

  • 19. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS, Brajachand N, Singh HL, Singh YM.
    J Commun Dis; 2005 Mar 19; 37(1):73-7. PubMed ID: 16637404
    [Abstract] [Full Text] [Related]

  • 20. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M.
    Int J Infect Dis; 2010 Jan 19; 14(1):e28-33. PubMed ID: 19464218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.